CCGB(SZ:300138) 智通财经网·2025-10-13 10:11Core Viewpoint - The company, Morning Light Bio (300138.SZ), anticipates a significant increase in net profit for the first three quarters of 2025, projecting a net profit attributable to shareholders between 278 million to 314 million yuan, representing a year-on-year growth of 344.05% to 401.55% [1] - The net profit after deducting non-recurring gains and losses is expected to be between 218 million to 254 million yuan, indicating a remarkable year-on-year increase of 1398.00% to 1645.38% [1] Financial Performance - The main plant extract products have seen a year-on-year increase in both revenue and gross profit, indicating a recovery in profitability [1] - The cottonseed business has experienced a market rebound, leading to a significant improvement in the operating environment, resulting in a turnaround from loss to profit [1] - Overall, the company's performance has improved compared to the same period last year [1]